US37611X1000 - Common Stock
These four small-cap stocks scan as deeply undervalued right now.
A few enterprising businesses are marketing themselves differently.
A few enterprising businesses are marketing themselves differently.
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that management will...
/PRNewswire/ -- Sojitz, a large Japanese general trading company with extensive networks within the Japanese bioeconomy, and Ginkgo Bioworks (NYSE: DNA), which...
/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and...
Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Most active stocks in Friday's session
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!
DNA stock results show that Ginkgo Bioworks Holdings met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today...
Traders have gravitated to meme stocks over the past year. But it's time to sell these three before the party ends.
Let's dive into these three high-potential penny stocks to discover whether or not they offer genuine investment opportunities.
/PRNewswire/ -- GreenLab, an emerging next generation plant-biotechnology company producing complex proteins in corn, and Ginkgo Bioworks (NYSE: DNA), which is...
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced its participation in...
Wednesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
This company has a long way to go before investors will see rewards.
Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering.
DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze.
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
/PRNewswire/ -- Across several sectors the use of artificial intelligence (AI) is making a huge impact, with healthcare emerging as possibly receiving the...
/PRNewswire/ -- Il Granaio delle Idee (IGDI), an innovative international developer and provider of clean label baking ingredients, and Ginkgo Bioworks (NYSE:...
The collaboration could help solve challenges for both businesses.
The collaboration could help solve challenges for both businesses.
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is developing the leading platform for cell programming and biosecurity, today announced the expansion of...
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it has been...
These stocks, a bargain today, are players to hold on to for the long term.
They might not be profitable yet, but they're swinging for the fences.
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its annual conference,...
/PRNewswire/ -- Prozomix, a UK-based biotech company focused on novel biocatalyst discovery and manufacturing, and Ginkgo Bioworks (NYSE: DNA), which is...
These stocks could rocket higher, but they also present significant risks.
/PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of...
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it has been...
/PRNewswire/ -- AQUA Cultured Foods, a food tech company producing alternative seafood options through the use of microbial fermentation, and Ginkgo Bioworks...
/PRNewswire/ -- Imagindairy, an Israeli-based foodtech company developing sustainable and commercially viable animal-free dairy proteins, and Ginkgo Bioworks...